Cholesterol in the cellular membrane (None in standard scientific use. If needed, may be abbreviated contextually as "membrane cholesterol" (not a formal abbreviation).)
Molecular Classification
Other (it is a sterol/lipid, not a protein, enzyme, channel, transporter, or receptor), Lipid molecule
Cardiovascular disease (role in atherosclerosis via reverse cholesterol transport; membrane cholesterol in macrophages)Neurodegenerative disease (implicated via effects on neuronal signaling, though not a classic target)Other (cholesterol-rich raft involvement in cancer, infection, and possibly inflammation via effects on signaling microdomains)
Cholesterol in the cellular membrane Overview
Cholesterol is a major non-polar lipid molecule, classified as a sterol, that is an essential structural component of all animal cellular membranes. It typically constitutes up to 40% of membrane lipids, where it modulates membrane fluidity, organizes membrane microdomains (lipid rafts), and regulates the function of integral membrane proteins. Cholesterol influences cell signaling, membrane permeability, and protein trafficking by structurally stabilizing or softening the membrane depending on context and temperature. It plays a central role in normal cell physiology and disease, particularly in cardiovascular and neurodegenerative disorders, but is not a direct molecular drug target in the classic pharmacological sense.
Mechanism of Action
Drugs reduce overall membrane cholesterol by inhibiting synthesis, absorption, or increasing efflux (not by directly binding "membrane cholesterol" as a unique target). Some toxins/agents (e.g., bacterial cytolysins) interact specifically with cholesterol-rich domains to disrupt membranes (biochemical/toxicological, not therapeutic).
Biological Functions
Structural component of membranes: provides membrane integrity and strength
Regulates membrane fluidity: modulates membrane rigidity and permeability in a temperature-dependent way
Formation of lipid rafts: microdomains important in signaling and trafficking
Modulation of integral membrane protein function
Regulation of cell signaling: via raft-associated domains and direct lipid-protein interactions
Affects membrane permeability
Influences endocytosis and protein anchoring
Maintains transbilayer asymmetry and participates in membrane organization
Disease Associations
Cardiovascular disease (role in atherosclerosis via reverse cholesterol transport; membrane cholesterol in macrophages)
Neurodegenerative disease (implicated via effects on neuronal signaling, though not a classic target)
Other (cholesterol-rich raft involvement in cancer, infection, and possibly inflammation via effects on signaling microdomains)
Not a direct drug target, but its levels are modulated in many diseases
Safety Considerations
Disruption of membrane cholesterol can compromise cell viability and alter function of many membrane proteins
Lowering cholesterol too much may affect neurological function or membrane integrity
Interacting Drugs
No direct drugs "target" membrane cholesterol as a specific moiety. However, drugs affecting overall cellular cholesterol include:
Statins (indirectly, by inhibiting biosynthesis)
Ezetimibe (affects absorption)
PCSK9 inhibitors (regulate LDL metabolism)
Amphotericin B (binds ergosterol in fungal membranes; not cholesterol specifically)
Associated Biomarkers
Biomarker
Membrane cholesterol levels/density (not in routine clinical use, but assessed in research on cardiovascular/neurodegenerative risk)
Plasma/serum cholesterol (proxy for cellular cholesterol in clinical practice, though not specific to membranes)